D.E. Shaw & Co’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $533K | Sell |
53,432
-50,693
| -49% | -$505K | ﹤0.01% | 2498 |
|
|
2025
Q1 | $622K | Buy |
104,125
+47,591
| +84% | +$284K | ﹤0.01% | 2374 |
|
|
2024
Q4 | $434K | Sell |
56,534
-69,227
| -55% | -$532K | ﹤0.01% | 2466 |
|
|
2024
Q3 | $1.28M | Sell |
125,761
-93,562
| -43% | -$955K | ﹤0.01% | 2053 |
|
|
2024
Q2 | $3.25M | Buy |
219,323
+82,603
| +60% | +$1.23M | ﹤0.01% | 1491 |
|
|
2024
Q1 | $1.86M | Sell |
136,720
-25,338
| -16% | -$346K | ﹤0.01% | 1813 |
|
|
2023
Q4 | $1.77M | Buy |
162,058
+47,600
| +42% | +$521K | ﹤0.01% | 1797 |
|
|
2023
Q3 | $1.25M | Buy |
114,458
+34,976
| +44% | +$383K | ﹤0.01% | 1946 |
|
|
2023
Q2 | $1.05M | Buy |
79,482
+6,816
| +9% | +$90.2K | ﹤0.01% | 2051 |
|
|
2023
Q1 | $989K | Buy |
72,666
+5,653
| +8% | +$76.9K | ﹤0.01% | 2211 |
|
|
2022
Q4 | $1.31M | Sell |
67,013
-18,732
| -22% | -$366K | ﹤0.01% | 2272 |
|
|
2022
Q3 | $1.63M | Buy |
85,745
+51,739
| +152% | +$985K | ﹤0.01% | 2240 |
|
|
2022
Q2 | $701K | Buy |
+34,006
| New | +$701K | ﹤0.01% | 2858 |
|
|
2021
Q2 | – | Sell |
-7,742
| Closed | -$265K | – | 3636 |
|
|
2021
Q1 | $265K | Buy |
7,742
+1,759
| +29% | +$60.2K | ﹤0.01% | 2704 |
|
|
2020
Q4 | $202K | Buy |
+5,983
| New | +$202K | ﹤0.01% | 2562 |
|